Vinge has advised Finnish listed company Fiskars Group in connection with acquisition

September 15, 2023 M&A

Vinge has advised Finnish listed company Fiskars Group in connection with its acquisition of renowned Danish design company Georg Jensen for EUR 151.5 million from private equity firm Investcorp. Closing of the transaction is expected to take place in the beginning of Q4 2023, subject to customary closing conditions.

Georg Jensen is an iconic Danish design company, founded in 1904, and is globally recognized for its pioneering craftsmanship and timeless design in jewelry, watches, silverware, homeware and more. Fiskars, Finland's oldest company, is known for manufacturing kitchenware and garden products, Fiskars also has a number of design brands in its portfolio, including the Danish porcelain company Royal Copenhagen. The acquisition of Georg Jensen is intended to strengthen Fiskars' portfolio of luxury brands and support Fiskars' global growth strategy. Vinge advised Fiskars alongside Accura in connection with the transaction.

Vinge's team consisted mainly of Magnus Hedsund, Sofie Nordgren and Niklas Törnell.



Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023